Vivo Opportunity Fund Holdings, L.P. - Mar 31, 2025 SCHEDULE 13G/A Report for Regulus Therapeutics Inc. Common Stock, $0.001 par value (RGLS)

Filing Manager
Vivo Opportunity Fund Holdings, L.P.
Reporting Manager
Vivo Opportunity Fund Holdings, L.P.
Security
Regulus Therapeutics Inc. Common Stock, $0.001 par value
Symbol
RGLS
Shares outstanding
69.1M shares
Disclosed Ownership
2.7M shares
Ownership
3.9%
Form type
SCHEDULE 13G/A
Date filed
5/15/2025, 08:35 AM
Date of event
Mar 31, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vivo Opportunity Fund Holdings, L.P. 3.9% 2.7M 2.7M 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity, LLC 3.9% 2.7M 2.7M 0 /s/ Kevin Dai Kevin Dai/Managing Member